vorinostat has been researched along with Proliferative Vitreoretinopathy in 1 studies
Vorinostat: A hydroxamic acid and anilide derivative that acts as a HISTONE DEACETYLASE inhibitor. It is used in the treatment of CUTANEOUS T-CELL LYMPHOMA and SEZARY SYNDROME.
vorinostat : A dicarboxylic acid diamide comprising suberic (octanedioic) acid coupled to aniline and hydroxylamine. A histone deacetylase inhibitor, it is marketed under the name Zolinza for the treatment of cutaneous T cell lymphoma (CTCL).
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Noh, SJ | 1 |
| Jeong, WJ | 1 |
| Rho, JH | 1 |
| Shin, DM | 1 |
| Ahn, HB | 1 |
| Park, WC | 1 |
| Rho, SH | 1 |
| Soung, YH | 1 |
| Kim, TH | 1 |
| Park, BS | 1 |
| Yoo, YH | 1 |
1 other study available for vorinostat and Proliferative Vitreoretinopathy
| Article | Year |
|---|---|
Sensitization of RPE cells by alphaB-crystallin siRNA to SAHA-induced stage 1 apoptosis through abolishing the association of alphaB-crystallin with HDAC1 in SC35 speckles.
Topics: alpha-Crystallin B Chain; Apoptosis; Blotting, Western; Cell Count; Cells, Cultured; DNA; Down-Regul | 2008 |